OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
448359

JMDC Inc

Business Support ServicesVerified

JMDC Inc maintains a debt-to-equity ratio of 0.6, indicating a relatively balanced capital structure. The company's liquidity position is characterized as medium, with a current ratio of 2.72, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, JMDC Inc reports a return on equity (ROE) of 9.32% and a return on assets (ROA) of 5.09%. These figures suggest the company is generating reasonable returns for its shareholders and effectively utilizing its assets. However, the ROE is below the typical threshold for high-performing firms in the Business Support Services industry, indicating there is room for improvement in leveraging equity to generate returns. The company's revenue is primarily concentrated in the health care technology segment, as indicated by its industry classification. While the input data does not provide a detailed breakdown of geographic exposure, the company's primary operations are likely centered in Japan, given its ticker listing on the Tokyo Stock Exchange. There is no indication of significant international diversification in the provided data. Looking ahead, JMDC Inc's growth trajectory is expected to be moderate. The company's free cash flow of 4.114 billion JPY and operating cash flow of 14.685 billion JPY suggest it has the capacity to fund operations and potentially reinvest in growth opportunities. However, the absence of specific revenue growth projections in the input data limits the ability to quantify the expected growth rate. The risk assessment for JMDC Inc highlights a medium liquidity risk and a low dilution risk. The company's capital structure includes 46.888 billion JPY in long-term debt, which, while manageable, could pose a challenge if interest rates rise or if the company faces unexpected cash flow disruptions. The dilution risk is considered low, with no significant dilution potential identified in the basic shares outstanding. Recent events and disclosures for JMDC Inc include analyst estimates that suggest a generally positive outlook. The mean price target of 5,238.33 JPY and the median price target of 5,200.00 JPY indicate that analysts expect the stock to appreciate from its current level. The mean recommendation of 1.86, with 3 strong-buy and 10 buy ratings, further supports this positive sentiment.

30-day price · 4483(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyJMDC Inc
Ticker4483.T
SectorIndustrials
BusinessIndustrial & Commercial Services
Industry groupIndustrial & Commercial Services
IndustryBusiness Support Services
AI analysis

Business. JMDC Inc provides industrial services, primarily in the health care technology sector, generating revenue through the provision of business support services.

Classification. JMDC Inc is classified under the Industrials economic sector, Industrial & Commercial Services business sector, and Business Support Services industry, with a confidence level of 0.92.

JMDC Inc maintains a debt-to-equity ratio of 0.6, indicating a relatively balanced capital structure. The company's liquidity position is characterized as medium, with a current ratio of 2.72, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, JMDC Inc reports a return on equity (ROE) of 9.32% and a return on assets (ROA) of 5.09%. These figures suggest the company is generating reasonable returns for its shareholders and effectively utilizing its assets. However, the ROE is below the typical threshold for high-performing firms in the Business Support Services industry, indicating there is room for improvement in leveraging equity to generate returns. The company's revenue is primarily concentrated in the health care technology segment, as indicated by its industry classification. While the input data does not provide a detailed breakdown of geographic exposure, the company's primary operations are likely centered in Japan, given its ticker listing on the Tokyo Stock Exchange. There is no indication of significant international diversification in the provided data. Looking ahead, JMDC Inc's growth trajectory is expected to be moderate. The company's free cash flow of 4.114 billion JPY and operating cash flow of 14.685 billion JPY suggest it has the capacity to fund operations and potentially reinvest in growth opportunities. However, the absence of specific revenue growth projections in the input data limits the ability to quantify the expected growth rate. The risk assessment for JMDC Inc highlights a medium liquidity risk and a low dilution risk. The company's capital structure includes 46.888 billion JPY in long-term debt, which, while manageable, could pose a challenge if interest rates rise or if the company faces unexpected cash flow disruptions. The dilution risk is considered low, with no significant dilution potential identified in the basic shares outstanding. Recent events and disclosures for JMDC Inc include analyst estimates that suggest a generally positive outlook. The mean price target of 5,238.33 JPY and the median price target of 5,200.00 JPY indicate that analysts expect the stock to appreciate from its current level. The mean recommendation of 1.86, with 3 strong-buy and 10 buy ratings, further supports this positive sentiment.
Key takeaways
  • JMDC Inc maintains a balanced capital structure with a debt-to-equity ratio of 0.6.
  • The company's return on equity of 9.32% and return on assets of 5.09% indicate reasonable profitability.
  • The company's liquidity position is characterized as medium, with a current ratio of 2.72.
  • Analysts have a generally positive outlook, with a mean price target of 5,238.33 JPY and a mean recommendation of 1.86.
  • The company's revenue is primarily concentrated in the health care technology segment.
  • The company's dilution risk is considered low, with no significant dilution potential identified.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$41.72B
Gross profit$23.85B
Operating income$8.71B
Net income$7.28B
R&D
SG&A
D&A
SBC
Operating cash flow$14.69B
CapEx-$3.69B
Free cash flow$4.11B
Total assets$143.02B
Total liabilities$65.00B
Total equity$78.02B
Cash & equivalents$32.18B
Long-term debt$46.89B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$78.02B
Net cash-$14.71B
Current ratio2.7
Debt/Equity0.6
ROA5.1%
ROE9.3%
Cash conversion2.0%
CapEx/Revenue-8.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Industrial Services · cohort 6 companies
Metric4483Activity
Op margin20.9%11.2% medp25 7.1% · p75 18.5%top quartile
Net margin17.4%13.8% medp25 13.8% · p75 13.8%top quartile
Gross margin57.2%94.7% medp25 62.9% · p75 126.4%bottom quartile
R&D / revenue6.0% medp25 6.0% · p75 6.0%
CapEx / revenue-8.8%6.7% medp25 4.4% · p75 7.4%bottom quartile
Debt / equity60.0%136.7% medp25 101.5% · p75 217.7%bottom quartile
Observations
IR observations
Mean price target5,238.33 JPY
Median price target5,200.00 JPY
High price target6,700.00 JPY
Low price target3,650.00 JPY
Mean recommendation1.86 (1=strong buy, 5=strong sell)
Strong-buy count3.00
Buy count10.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate113.55 JPY
Last actual EPS111.34 JPY
Source: analysis-pipeline (hybrid)Generated: 2026-05-24 19:43 UTCJob: fe4f1ec2